BON

Bon Natural Life

1.91 USD
+0.09
4.95%
At close Updated Sep 12, 4:00 PM EDT
Pre-market
After hours
1.90
-0.01
0.52%
1 day
4.95%
5 days
26.49%
1 month
46.92%
3 months
18.63%
6 months
-90.68%
Year to date
-95.48%
1 year
-95.28%
5 years
-99.89%
10 years
-99.89%
 

About: Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.

Employees: 97

0
Funds holding %
of 7,462 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

490% more capital invested

Capital invested by funds: $6.22K [Q1] → $36.7K (+$30.4K) [Q2]

33% more funds holding

Funds holding: 3 [Q1] → 4 (+1) [Q2]

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

26.72% more ownership

Funds ownership: 0.06% [Q1] → 26.78% (+26.72%) [Q2]

Financial journalist opinion

Neutral
PRNewsWire
4 days ago
BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products
XI'AN, China , Sept. 9, 2025 /PRNewswire/ -- Bon Natural Life Limited (NASDAQ: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced it has entered into a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd.
BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products
Neutral
PRNewsWire
11 days ago
BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform
XI'AN, China , Sept. 2, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a groundbreaking identification of a class of natural polyphenolic compounds from a tea-derived product via its AI-Powered new drug research and development (R&D) platform.
BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform
Neutral
PRNewsWire
1 month ago
BON Announces Reciept of Nasdaq Compliance Letter
XI'AN, China , Aug. 5, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced reciept of compliance notification from the Nasdaq Stock Market LLC. As previously reported on a Form 6-K filed with the U.S. Securities and Exchange Commission on July 11, 2025, Bon Natural Life Limited ( "the Company") received notification from the Nasdaq Hearings Panel (the "Panel") that the Company had regained compliance with Listing Rule 5550(a)(2) (the "Bid Price Rule").
BON Announces Reciept of Nasdaq Compliance Letter
Neutral
PRNewsWire
1 month ago
BON Launches AI-Powered New Drug Research and Development
XI'AN, China , July 30, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced the official launch of its AI-driven drug research and development (R&D) business. Leveraging its extensive library of natural compounds - many derived from Traditional Chinese Medicine (TCM) - the Company will apply artificial intelligence algorithms to identify high potential lead compounds, marking a significant evolution in its pharmaceutical strategy.
BON Launches AI-Powered New Drug Research and Development
Neutral
PRNewsWire
1 month ago
BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd
XI'AN, China , July 21, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural health and personal care industries, today announced it has entered into a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co. Ltd. ("Huahai Keyuan").
BON Announces $22 Million Distribution Agreement for Weight Loss Products with Beijing Huahai Keyuan Technology Co., Ltd
Neutral
PRNewsWire
2 months ago
BON Announces Nasdaq Compliance
XI'AN, China , July 14, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced that it has regained compliance with Nasdaq's continued listing requirements. On July 2, 2025, the Company received formal notice from the Nasdaq Hearings Panel confirming that BON has successfully met the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2).
BON Announces Nasdaq Compliance
Neutral
PRNewsWire
2 months ago
Bon Announces Breakthrough Order for $16 Million Gut-Health Products
XI'AN, China , July 2, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solutions provider in the natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co., Ltd., a leading wellness company in China ("Huahai Keyuan").
Bon Announces Breakthrough Order for $16 Million Gut-Health Products
Neutral
GlobeNewsWire
2 months ago
Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.
XI'AN, China, June 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“Bon” or the “Company”), a leading bio-ingredient solutions provider for natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Tianjin Merrill-Youli Trading Co., Ltd., a prominent Asia-Pacific fragrance chemical distributor (“Merrill-Youli”).
Bon Natural Life Announces Distribution Agreement with Tianjin Merrill-Youli Trading Co., Ltd.
Neutral
GlobeNewsWire
3 months ago
BON Announces Share Repurchase Program for up to US$1.0 Million
XI'AN, China, June 03, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced its board of directors approved a share repurchase program pursuant to which the Company may purchase up to $1.0 million of its Class A ordinary shares. Under the share repurchase program, the Company is authorized to repurchase its shares from time to time in the open market.
BON Announces Share Repurchase Program for up to US$1.0 Million
Neutral
GlobeNewsWire
3 months ago
BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade
XI'AN, China, May 22, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive sales cooperation agreement with Shanghai Risesun International Trade Co., Ltd., a leading functional ingredient distributor in China.
BON Announces Launch of Tea Pigment Digestive Health Products and Cooperation Agreement Signed with Shanghai Risesun International Trade
Charts implemented using Lightweight Charts™